Home6919 • TPE
add
Caliway Biopharmaceuticals Co Ltd
Previous close
$107.00
Day range
$106.00 - $108.50
Year range
$58.10 - $277.00
Market cap
168.18B TWD
Avg Volume
14.16M
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
| (TWD) | Mar 2026info | Y/Y change |
|---|---|---|
Revenue | 2.00K | — |
Operating expense | 245.83M | 8.07% |
Net income | -107.75M | 38.62% |
Net profit margin | -5.39M | — |
Earnings per share | -0.07 | 36.36% |
EBITDA | -239.81M | -8.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (TWD) | Mar 2026info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.89B | -48.81% |
Total assets | 9.54B | -1.23% |
Total liabilities | 173.79M | 82.25% |
Total equity | 9.36B | — |
Shares outstanding | 1.56B | — |
Price to book | 17.77 | — |
Return on assets | -6.47% | — |
Return on capital | -6.55% | — |
Cash Flow
Net change in cash
| (TWD) | Mar 2026info | Y/Y change |
|---|---|---|
Net income | -107.75M | 38.62% |
Cash from operations | -22.67M | 80.80% |
Cash from investing | 1.70B | -32.10% |
Cash from financing | 48.49M | 1,065.70% |
Net change in cash | 1.75B | -26.77% |
Free cash flow | -10.11M | 88.55% |
About
Founded
2012
Website
